Evaluation of the ability of pneumococcal conjugate vaccine to reduce the occurrence of respiratory infections and the resultant antibiotic drug use was conducted among day care attendees in Israel. It was observed that children who had received the 9-valent conjugate vaccine showed a 17% overall reduction in antibiotic usage. In particular, a 10% reduction in days of antibiotic usage for upper respiratory tract infections, 47% fewer days of antibiotic usage for lower respiratory tract infections, and 20% fewer days of antibiotic usage for otitis media (ear infections) when compared to children who did not receive PCV.
Full Citation:
Dagan, R., Sikuler-Cohen, M., Zamir, O., et al. 2001. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatric Infectious Disease Journal. 20(10).
Title of Article: Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees
Author(s): Dagan, R., Sikuler-Cohen, M., Zamir, O., et al
Publication Year: 2001
Publication Name: Pediatric Infectious Disease Journal
Publication Volume: 20(10)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/11642629/
DOI (Digital Object Identifier): 10.1097/00006454-200110000-00008
Topics: Antibiotic Resistance | Global Issues
Disease Vaccines: Pneumococcal disease/PCV/PPSV | Pneumonia
Countries: Israel
WHO Regions: Europe